Virginia Retirement Systems Et Al Gossamer Bio, Inc. Transaction History

Virginia Retirement Systems Et Al

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 16, 2023	SELL	$7.21 - $14.88 $225,673 - $465,744	-31,300 Reduced 72.79%	11,700 $140 Million
Q1 2022 Apr 21, 2022	BUY	$8.44 - $12.49 $60,768 - $89,928	7,200 Added 20.11%	43,000 $373,000
Q4 2021 Feb 03, 2022	SELL	$10.12 - $14.07 $22,264 - $30,954	-2,200 Reduced 5.79%	35,800 $405,000
Q3 2021 Oct 21, 2021	BUY	$7.25 - $13.23 $14,500 - $26,460	2,000 Added 5.56%	38,000 $478,000
Q2 2021 Aug 13, 2021	BUY	$8.0 - $9.75 $3,200 - $3,900	400 Added 1.12%	36,000 $292,000
Q1 2021 Apr 30, 2021	BUY	$8.63 - $10.94 $7,767 - $9,846	900 Added 2.59%	35,600 $329,000
Q4 2020 Feb 16, 2021	BUY	$8.3 - $13.59 $288,010 - $471,573	34,700 New	34,700 $336,000

109

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $84.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.